December 8, 2020
Philips Healthcare presented MyoStrain® at RSNA 2020 and discussed how MyoStrain's MRI-based cardiac diagnostic solutions may help transform cardiovascular care and enable physicians to quantify subtle changes in intra-myocardial heart function.
Read more >
March 31, 2020
Six new abstracts & posters showcasing MyoStrain were published as part of the American College of Cardiology’s (ACC) 69th Annual Scientific Session & Expo. The conference, which was scheduled to take place in Chicago, Illinois from March 28-30, was shifted to a virtual experience due to the...
Read more >
February 18, 2020
Myocardial Solutions (MSI) enabled 16 new abstracts and five podium presentations showcasing the latest in MyoStrain insights to the Society for Cardiovascular Magnetic Resonance’s (SCMR) 23rd Annual Scientific...
Read more >
October 11, 2019
A newly submitted clinical abstract utilizes MyoStrain to detect the cardiotoxic effects of Carfilzomib, a cancer therapy drug used in treating patients diagnosed with multiple myeloma.Conducted at Heidelberg University Hospital in Germany as part of an ongoing...
Read more >
September 5, 2019
Last weekend, the Myocardial Solutions (MSI) team attended the European Society of Cardiology (ESC) Congress 2019 to further the discussion of MyoStrain as a unique clinical tool for helping physicians proactively detect, monitor and manage heart failure. The ESC Congress took place from August...
Read more >
August 21, 2019
A new article on MyoStrain has been published in Nature Research’s recent Scientific Reports issue. Based upon an ongoing study conducted at German Heart Center Berlin (Charité University Medical Center Berlin), the article evaluates MyoStrain’s consistency in the acquisition of left ventricular...
Read more >
June 19, 2019
A new article demonstrating the significant cost savings that could be achieved using MyoStrain to detect and manage early heart failure was published in Health Economics Review. The article, authored by Avalon Health Economics (Avalon), compares MyoStrain to Echocardiography (ECHO), the most...
Read more >
June 13, 2019
The PROactive evaluation of function to Avoid Cardio-Toxicity (PROACT; NCT03862131) clinical trial has started at Washington University School of Medicine and Yale New Haven Hospital with patients receiving baseline MyoStrain exams before chemotherapy treatment. The study will evaluate the...
Read more >
May 29, 2019
Myocardial Solutions’ MyoStrain was featured in two different posters presented at the European Society of Cardiology's annual Heart Failure Congress 2019. The event was held in Athens, Greece on May 25-28, 2019. The lead author of the abstracts was Dr. Henning Steen, Head of Cardiac Imaging at...
Read more >
May 23, 2019
Myocardial Solutions provided MyoStrain cardiac function exams to attendees of the 2019 Hauptstadt Congress for Medicine and Health (Hauptstadt Kongress) in Berlin, Germany from Mary 21st – 23rd. In collaboration with medneo GmbH, Berlin Heart Institute and Philips, MyoStrain provided scan...
Read more >
